They will decide whether you should stop taking Keytruda. They may also recommend creams or antihistamines to help with your rash and itchiness. Skin reactions are a common side effect of Keytruda ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Adding ...

The EV-302/KN-A39 trial demonstrated improved overall survival and PFS with Padcev and Keytruda compared to standard chemotherapy. Neuropathy, skin rash, and hyperglycemia following enfortumab vedotin ...

Allen, who lives in New York, has been battling stage 4 synovial sarcoma since July 2020, and she has gained viral attention ...

Common adverse events (AEs) associated with Keytruda include fatigue, diarrhea, rash, and nausea. For patients who receive Keytruda in combination with chemotherapy, the most common AEs included ...

MSD’s checkpoint inhibitor Keytruda has been cleared by the FDA for use in newly diagnosed cervical cancer patients with less severe disease, becoming the first anti-PD-1/PD-L1 immunotherapy for ...

Merck & Co's FDA approval for Keytruda in advanced liver cancer looks secure, after an Asian clinical trial found that the cancer immunotherapy improved survival in these patients. Keytruda ...

Merck stock tumbled Monday after Summit Therapeutics' cancer drug outperformed blockbuster Keytruda in a study of lung cancer ...

Results also show that reducing the Padcev dose at treatment initiation may benefit older patients with urothelial carcinoma, a type of bladder cancer.